Open Access. Powered by Scholars. Published by Universities.®

Biological Factors Commons™

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 3 of 3

Full-Text Articles in Biological Factors

Association Between Lifestyle And Dietary Habits With C-Reactive Protein And Glucose: A Cross-Sectional Study, Mohammad Ariful Islam, Reaz Morshed, Shamim Alam, Jakir Hossain, Md Shahedul Islam Jan 2026

Association Between Lifestyle And Dietary Habits With C-Reactive Protein And Glucose: A Cross-Sectional Study, Mohammad Ariful Islam, Reaz Morshed, Shamim Alam, Jakir Hossain, Md Shahedul Islam

School of Integrative Biological & Chemical Sciences Faculty Publications

Background and Aims: Lifestyle and diet influence chronic disease risk through their impact on systemic inflammation. This research evaluated the association among dietary habits, physical activity, and inflammatory biomarkers, specifically glucose and C-reactive protein (CRP). Methods: This cross-sectional study examined lifestyle, sociodemographic, and nutritional indicators using a structured questionnaire, which was adapted from the WHO STEPwise guideline. A total of 200 participants were included based on their attendance for CRP and glucose assays at two health centers between May and September 2023 in Bangladesh. Results: Among participants with high fiber intake (> 20 g/day), 22% had normal blood glucose levels …


Long-Term Safety And Comparative Efficacy Of Il-17 Inhibitors In Treating Ankylosing Spondylitis, Alyssa L. Sepulveda, Yolanda V. Gutierrez, Ronald A. Shaju Mar 2025

Long-Term Safety And Comparative Efficacy Of Il-17 Inhibitors In Treating Ankylosing Spondylitis, Alyssa L. Sepulveda, Yolanda V. Gutierrez, Ronald A. Shaju

Research Symposium

Background:
Ankylosing Spondylitis (AS) is a chronic inflammatory disease affecting the axial skeleton, characterized by spinal stiffness, sacroiliitis, and potential vertebral fusion. While nonsteroidal anti-inflammatory drugs (NSAIDs) and tumor necrosis factor (TNF) inhibitors are first-line treatments, IL-17 inhibitors, such as secukinumab and ixekizumab, are used in patients with inadequate response or contraindications to TNF inhibitors. These targeted therapies address IL-17’s role in driving inflammation and structural damage in AS.

Methods:
A systematic review was conducted using PubMed, Science Direct, and Cochrane to identify studies published between 2000 and 2025. Keywords included “Ankylosing spondylitis” and “IL-17 inhibitors” and “efficacy.” Inclusion criteria …


Observing Growth Effects Of Pigment Epithelium-Derived Factor On Human Retinal Pericytes In Vitro, Anjalee Choudhury, Andrew Tsin, Zachary Perez, Fransisco Elisarraras Sep 2019

Observing Growth Effects Of Pigment Epithelium-Derived Factor On Human Retinal Pericytes In Vitro, Anjalee Choudhury, Andrew Tsin, Zachary Perez, Fransisco Elisarraras

School of Medicine Publications

The purpose of this study is to investigate and determine the role of PEDF in the pathogenesis of diabetic retinopathy as induced by advanced glycation end-products (AGEs). Human retinal pericytes were isolated from donors and will be measured for cell proliferation under the influence of PEDF both in the presence and absence of AGEs. Expected outcomes involve both the maintenance and increased survival of HRPs after treatment with PEDF under stimulated hyperglycemic conditions.